LGC acquires LINK and strengthens its oligo reagents offering

News (ZH) - LINK Technologies is a premier supplier of speciality reagents for oligonucleotide synthesis

LGC acquires Axolabs and invests in GMP manufacturing capacity for therapeutic nucleic acids

News (ZH) - Moves strengthen existing analytical and bioanalytical drug development service offering

Innovate UK Awards Grant to MiNA Therapeutics and LGC LINK

News (ZH) - Funding to develop liver targeted gene activation therapies